Healthcare professional surveys to investigate the implementation of the isotretinoin Pregnancy Prevention Programme: a descriptive study

Prescriptive contraceptive use among isotretinoin users in the Netherlands in comparison with non-users: a drug utilisation study

(2012) Hubertina J.M.J. Crijns et al.   PHARMACOEPIDEMIOLOGY AND DRUG SAFETY

Implementation of the Harmonized EU Isotretinoin Pregnancy Prevention Programme

(2011) Ineke Crijns et al.   DRUG SAFETY

Dermatologists’ level of compliance with the prescription guidelines of isotretinoin for females of childbearing potential

(2011) Khalid M. AlGhamdi et al.   INTERNATIONAL JOURNAL OF DERMATOLOGY

The impact of the iPLEDGE program on isotretinoin fetal exposure in an integrated health care system

(2011) Janet Shin et al.   JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY

Web-based Questionnaires: The Future in Epidemiology?

(2010) M. M. H. J. van Gelder et al.   AMERICAN JOURNAL OF EPIDEMIOLOGY

Compliance with pregnancy prevention programmes of isotretinoin in Europe: a systematic review

(2010) H.J.M.J. Crijns et al.   BRITISH JOURNAL OF DERMATOLOGY

Isotretinoin Use and Compliance with the Dutch Pregnancy Prevention Programme

(2010) Martina Teichert et al.   DRUG SAFETY

Isotretinoin Exposure during Pregnancy

(2010) Elisabeth Autret-Leca et al.   DRUG SAFETY

Aide au bon usage de l’isotrétinoïne en pratique libérale : observatoire prospectif de 1263 patients acnéiques

(2009) M. Jeanmougin et al.   ANNALES DE DERMATOLOGIE ET DE VENEREOLOGIE

Isotretinoin exposure and pregnancy outcome: an observational study of the Berlin Institute for Clinical Teratology and Drug Risk Assessment in Pregnancy

(2009) Christof Schaefer et al.   ARCHIVES OF GYNECOLOGY AND OBSTETRICS

Resident physician and hospital pharmacist familiarity with patient discharge medication costs

(2009) Kerry Wilbur   PHARMACY WORLD & SCIENCE